Get Premium

Get Premium

Dominate Financial Markets with Stock Target Advisor Premium Features

Discover
Discover

Explore new stock opportunities and market trends for better investment decisions.
- Analyst Ratings & Stock Picks
- Top Picks By AI
- Latest Analyst Ratings
- Analyst Directory
- Worst Stocks
- Sector Ratings & Performance
- Smart Filters
- Best Penny Stocks
- Best Dividend Stocks
- Best Crypto Stocks
- Best Performing Stocks
- Worst Performing Stocks
- Highest Income ETFs
Research
Research

Access in-depth stock analysis and expert evaluations to guide your investments
- Automatic Selection
- Stocks/ETF Screener
- Query Builder
- Analyst Screener
- Automated Research Reports
- Best Stocks Filters
- Thematic Stock Screens
- Sector Stock Screens
Learn
Learn

Utilize our extensive educational resources designed to enhance your investing knowledge and skills
- Market News & Insights
- Stock Target Advisor Insights
- Tutorials
- Market News
- Stock Calendars
- Earnings Calendar
- IPO Calendar
- Splits Calendar
Watchlists & Portfolios
Watchlists & Portfolios

Easily manage, track, and optimize your stock selections for maximum returns
Engage
Engage

Connect with the investing community and access free widgets for better stock insights
Pricing

Limited Time Offer: Save Up to 70% on all Packages

Leverage our advanced stock screeners, a custom dashboard, and market-leading tools to maximize your returns. Claim Now

ARCG:LSE ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

Current Price GBX 366.75 +6.78 ( +1.88)%

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (ARCG:LSE) Stock Analysis and Price Targets

ETF | Others | LSE

Target Add to Watchlist

Take a Tour

N/A

Average Analyst
Rating

Very Bearish

Stock Target Advisor
Analysis

N/A

Average User
Rating

Last Closing Price

GBX 366.75

Change

+6.78 (+1.88)%

Market Cap

GBX 3.68M

Volume

0.01M

Avg User Target

N/A

ARCG:LSE

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP (GBX)

ETF | LSE

GBX 366.75

+6.78 ( +1.88)%

Watchlist

Discussions

New Post

No discussions yet.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like

There is nothing we particularly like

What not to like

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.